An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Li N, Zhu Z, Deng Y, Tang R, Hui H, Kang Y, Rana TM.Li N, et al.EMBO Rep. 2023 Oct 9;24(10):e55506. doi: 10.15252/embr.202255506. Epub 2023 Sep 14.EMBO Rep. 2023.PMID: 37705505Free PMC article.
Li N, Kang Y, Wang L, Huff S, Tang R, Hui H, Agrawal K, Gonzalez GM, Wang Y, Patel SP, Rana TM.Li N, et al.Proc Natl Acad Sci U S A. 2020 Aug 18;117(33):20159-20170. doi: 10.1073/pnas.1918986117. Epub 2020 Aug 3.Proc Natl Acad Sci U S A. 2020.PMID: 32747553Free PMC article.
Wang L, Hui H, Agrawal K, Kang Y, Li N, Tang R, Yuan J, Rana TM.Wang L, et al. Among authors: li n.EMBO J. 2020 Oct 15;39(20):e104514. doi: 10.15252/embj.2020104514. Epub 2020 Sep 23.EMBO J. 2020.PMID: 32964498Free PMC article.
Li N, Hui H, Bray B, Gonzalez GM, Zeller M, Anderson KG, Knight R, Smith D, Wang Y, Carlin AF, Rana TM.Li N, et al.Cell Rep. 2021 May 11;35(6):109091. doi: 10.1016/j.celrep.2021.109091. Epub 2021 May 3.Cell Rep. 2021.PMID: 33961823Free PMC article.
Li N, Rana TM.Li N, et al.STAR Protoc. 2022 Mar 18;3(1):101067. doi: 10.1016/j.xpro.2021.101067. Epub 2021 Dec 8.STAR Protoc. 2022.PMID: 34901888Free PMC article.
N (6) -methylation of adenosine (m6A) is the most abundant internal mRNA modification and is an important post-transcriptional regulator of gene expression. ...For complete details on the use and execution of this protocol, please refer to Li et al. (2021)....
N (6) -methylation of adenosine (m6A) is the most abundant internal mRNA modification and is an important post-transcriptional regula …
Li N, Rana TM.Li N, et al.Wiley Interdiscip Rev RNA. 2022 Nov;13(6):e1720. doi: 10.1002/wrna.1720. Epub 2022 Feb 12.Wiley Interdiscip Rev RNA. 2022.PMID: 35150188Free PMC article.Review.
Zhu Z, Tang R, Huff S, Kummetha IR, Wang L, Li N, Rana TM.Zhu Z, et al. Among authors: li n.Cancer Res Commun. 2023 Jan 24;3(1):119-129. doi: 10.1158/2767-9764.CRC-21-0186. eCollection 2023 Jan.Cancer Res Commun. 2023.PMID: 36968224Free PMC article.
Wang S, Li W, Wang L, Tiwari SK, Bray W, Wu L, Li N, Hui H, Clark AE, Zhang Q, Zhang L, Carlin AF, Rana TM.Wang S, et al. Among authors: li w, li n.bioRxiv [Preprint]. 2024 May 3:2024.05.01.591800. doi: 10.1101/2024.05.01.591800.bioRxiv. 2024.PMID: 38746287Free PMC article.Preprint.
Wu ZH, Li N, Gao ZZ, Chen G, Nie L, Zhou YQ, Jiang MZ, Chen Y, Chen J, Mei XF, Hu F, Wang HB.Wu ZH, et al. Among authors: li n.Cancers (Basel). 2022 Oct 10;14(19):4964. doi: 10.3390/cancers14194964.Cancers (Basel). 2022.PMID: 36230887Free PMC article.
Wu ZH, Li N, Mei XF, Chen J, Wang XZ, Guo TT, Chen G, Nie L, Chen Y, Jiang MZ, Wang JT, Wang HB.Wu ZH, et al. Among authors: li n.J Immunother Cancer. 2022 Mar;10(3):e004054. doi: 10.1136/jitc-2021-004054.J Immunother Cancer. 2022.PMID: 35256517Free PMC article.